Posts

Showing posts with the label Pure Red Cell Aplasia Market

Pure Red Cell Aplasia Market Top Scenario, SWOT Analysis, Business Overview, Forecast 2030

  Pure red cell aplasia   is a type of rare disorder related to the production of blood in the body. Spongy tissue between bone marrow fails to produce sufficient blood for the body leading to anaemic conditions. In pure red cell aplasia, only red blood cells of the blood are affected, whereas white blood cells are at normal levels. Red blood cells play a key role in carrying oxygen in the body. Pure red cell aplasia leads to increased heart rate, decrease in physical activity and pale appearance. Pure red cell aplasia can be acquired or genetic. According to the National Organization of Rare Disorders, globally there are approximately 5000 active cases of Diamond Blackfan Anaemia which is inherited pure red cell aplasia. Due to the Covid-19 pandemic, the lockdown has been implemented in several countries leading to delay of manufacturing activities and disruption of supply chain impacting pure red cell aplasia market. There has been a significant decline in hospital visits and treatme